Arkolith/Insider Trading/ATHA/Form 4

San Martin Javier

CHIEF MEDICAL OFFICERAthira Pharma, Inc. (ATHA) · full profile →Form 4 · filed Jan 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2025Sell(S)11K$0.56$6K36K
Dec 31, 2024Option exercise(M)47K—$047K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2024Option exercise(M)47K—$093K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-000544) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML